CA46942-2B - 0x000000000000690A
Healthy Males & Females
Row
* Stipend may pay up to reflected amount.
Start Date:
March 17, 2026 - 11:00am
End Date:
April 4, 2026 - 12:30pm
Study Details
Study Number: CA46942
Group Number: 2B
Study Requirement: Healthy Normal Female
Stipend: up to $3,500.00
Study Criteria
Age: 18 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat cancer.
Route of Administration: Oral
Blood Draws: 29
Study Schedule
Schedule Type: Short Term
Study Length: 5 Night Stay & 1 Phone Call
Screening Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 3/3/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 3/3/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Tuesday | 3/17/2026 11:00:00 AM | 3/22/2026 10:30:00 AM | 1 | Phoenix | |
| Phone participant | Saturday | 4/4/2026 12:30:00 PM | 2 | Phoenix |
